Stock Comparison
ABT vs GMED
Abbott Laboratories and Globus Medical side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$192.35B
$11.15B
P/E (TTM)
35.7
21.0
Forward P/E
20.0
18.1
Price/Sales
4.1
3.5
Price/Book
3.7
2.3
EV/EBITDA
18.6
11.2
Dividend Yield
1.66%
—
Profitability
Net Margin
13.91%
18.92%
Operating Margin
18.17%
17.62%
Return on Equity
10.60%
11.80%
Return on Assets
5.33%
8.74%
Growth (YoY)
Revenue Growth
13.00%
5.90%
Earnings Growth
-47.50%
-26.20%
Price & Risk
Beta
0.6
1.0
52-Week High
$134.48
$96.82
52-Week Low
$82.56
$55.10
Analyst Target
$118.42
$104.15
Compare ABT and GMED your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.